PROTEO-ULaval would like to congratulate Professor Denis Leclerc, full professor in the Department of Microbiology-Infectiology and Immunology at Université Laval and member of the Infection and Immunity Axis at the Centre de recherche du CHU de Québec-Université Laval and member of PROTEO-ULaval, on obtaining $1.5 million in funding from Médicament Québec.
His project, entitled VaxSynergy - Empowering innovation in vaccine development through a collaborative ecosystem, will set up an integrated platform bringing together a range of academic and industrial expertise to accelerate the development of innovative subunit vaccines and adjuvants, from discovery through to clinical applications.